Introducing: Pathway. Part of TrialHub’s Patient Journey.

Introducing: Pathway. Part of TrialHub’s Patient Journey.

Care complexity across countries, simplified for trial strategy

Care complexity across countries, simplified for trial strategy

Care complexity across countries, simplified for trial strategy

"Moderate-to-severe" means 12 different things in 12 countries.

"Moderate-to-severe" means 12 different things in 12 countries.

Your protocol finds out at the first amendment. Patient Journey – Pathway shows you first. One interactive map of how care actually differs, across every country you're evaluating.


76 countries

76 countries

all indications

all indications

traceable sources

traceable sources

One map. Every country.

Transparent data.

One map. Every country.

Transparent data.

See the care pathway for each country you're evaluating in a single interactive view: a shared route, with annotated differences, adherence challenges, treatment gaps and barriers flagged directly on it. All translated into trial recommendations afterwards.


The map is constructed by analyzing the individual Patient Journeys of the included countries in detail, balancing clinical nuance and complexity with what matters most visually.


Reimbursement and standard of care data—mapped on the step it affects to reveal actual clinical practice from pre-diagnosis to continued care.

Know where your eligible patients are

Know where your eligible patients are

Access to therapy, treatment history, diagnosis timelines—they decide who's reachable, and where. Change one protocol assumption, and the countries that looked attractive change as well.

Challenge your eligibility criteria

"Moderate-to-severe." "Refractory." "Treatment-naive." Each means a different patient in a different healthcare system. See where a criterion empties the patient pool before it reaches a single site.

Select sites around actual barriers

Special access programs. Region-locked specialist care. GP gatekeeping in some countries, direct access in others. Pathway surfaces both country- and disease-specific challenges and highlights the nuance, so site selection matches the ground.

* Compare 20+ countries. Then dive deeper to understand patients and care teams in each one.

* Compare 20+ countries. Then dive deeper to understand patients and care teams in each one.

We are the first to map the full care pathway, across every country, sourced, in one place. 

We are the first to map the full care pathway, across every country, sourced, in one place. 

Not just drugs and claims data or static reports.

Not just drugs and claims data or static reports.

TrialHub’s proprietary technology, validated by our in-house medical experts, identifies the most reliable data sources for each disease in each country.

TrialHub’s proprietary technology, validated by our in-house medical experts, identifies the most reliable data sources for each disease in each country.

Each Pathway is built on hundreds of references: from National Competent Authorities and HTA decisions to peer-reviewed literature, clinical guidelines, and patient organisation publications.


Each Pathway is built on hundreds of references: from National Competent Authorities and HTA decisions to peer-reviewed literature, clinical guidelines, and patient organisation publications.


Every fact links directly to its source, so you can see exactly where the data comes from and trust what’s behind every insight.

Every fact links directly to its source, so you can see exactly where the data comes from and trust what’s behind every insight.

Built for the hard cases

Built for the hard cases

Tested on conditions too rare or too newly described for claims data or EHRs to say anything at all. 

Tested on conditions too rare or too newly described for claims data or EHRs to say anything at all. 

If your indication is complex, this is exactly where Pathway shines.

Bring your countries.

See them on one map.

Bring your countries.

See them on one map.

Bring your countries.

See them on one map.

Don't fix recruitment challenges. Prevent them.

Don't fix recruitment challenges. Prevent them.

© 2026 All rights reserved.